Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The submission is supported by the SURPASS CVOT trial, which showed that Mounjaro reduced the risk of MACE including cardiovascular (CV) death, heart attack, or stroke by 8% compared with dulaglutide (Trulicity
Vial-based protocols require verification of the source, concentration, sterility expectations, and current rules before dose math
Given the relatively high level of gross Medicare Part D spending as of 2022 for the two semaglutide products combined, Ozempic and Rybelsus, its possible that Medicare could select this product for drug price negotiation as early as 2025, which would be just over seven years past its earliest FDA approval in late 2017
However, cost isnt the sole concern
Silence food-noise at the source
US$ 25.59
US$ 21.79
US$ 27.97
US$ 24.00
